Gilead Sciences
GILD
1,574 hedge funds and large institutions have $71.2B invested in Gilead Sciences in 2016 Q4 according to their latest regulatory filings, with 172 funds opening new positions, 525 increasing their positions, 769 reducing their positions, and 126 closing their positions.
75.4% more ownership
Funds ownership: 0% → 75.4% (+75%)
37% more first-time investments, than exits
New positions opened: 172 | Existing positions closed: 126
1% more funds holding
Funds holding: 1,561 → 1,574 (+13)
10% less capital invested
Capital invested by funds: $78.8B → $71.2B (-$7.65B)
13% less funds holding in top 10
Funds holding in top 10: 106 → 92 (-14)
19% less call options, than puts
Call options by funds: $1.82B | Put options by funds: $2.26B
32% less repeat investments, than reductions
Existing positions increased: 525 | Existing positions reduced: 769
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIG
American International Group
New York
|
+$430M |
| 2 |
D.E. Shaw & Co
New York
|
+$253M |
| 3 |
Renaissance Technologies
New York
|
+$247M |
| 4 |
State Street
Boston,
Massachusetts
|
+$192M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$184M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$482M |
| 2 |
Edgewood Management
Greenwich,
Connecticut
|
-$428M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$231M |
| 4 |
JP Morgan Chase
New York
|
-$209M |
| 5 |
MTB
Mizuho Trust & Banking
Tokyo,
Japan
|
-$174M |
GILD Hedge Fund Activity: Q4 2016 in Review
1,574 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q4 2016, worth a combined $71.2B — down 9.7% from $78.8B a quarter earlier.
Buyers outnumbered sellers: 172 funds opened new GILD positions and 126 closed out — a net gain of 46 holders — while 525 added to existing stakes and 769 trimmed.
The largest buyer was American International Group, adding an estimated $430M. The largest seller was Fidelity Investments, cutting an estimated $482M.
- 1,574 institutional investors held Gilead Sciences (GILD) as of Q4 2016, up from 1,561 in Q3 2016.
- Funds reported $71.2B of Gilead Sciences stock for Q4 2016, down 9.7% quarter-over-quarter.
- 172 funds opened new Gilead Sciences positions in Q4 2016 and 126 closed out, a net change of +46 holders.
- The largest Gilead Sciences buyer in Q4 2016 was American International Group, an estimated $430M added.
- The largest Gilead Sciences seller in Q4 2016 was Fidelity Investments, an estimated $482M sold.
Based on aggregated 13F filings for Q4 2016.